Tyrosine nitration of a humanized anti-cocaine mAb differentially affects ligand binding of cocaine and its metabolites

被引:3
|
作者
Kirley, Terence L. [1 ]
Greis, Kenneth D. [2 ]
Norman, Andrew B. [1 ]
机构
[1] Univ Cincinnati, Coll Med, Dept Pharmacol & Syst Physiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Coll Med, Dept Canc Biol, Prote Lab, 3125 Eden Ave, Cincinnati, OH 45267 USA
基金
美国国家卫生研究院;
关键词
Monoclonal antibody; Cocaine binding; Tyrosine nitration; DASPMI rotor dye; Differential scanning fluorimetry; Ligand affinity; MONOCLONAL-ANTIBODY; FAB FRAGMENT;
D O I
10.1016/j.bbrep.2022.101278
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tetranitromethane was used to selectively modify tyrosine residues of a humanized anti-cocaine mAb (h2E2), under development for the treatment of cocaine use disorders. The effect of mild tyrosine nitration on the affinity of cocaine and two high affinity cocaine metabolites, cocaethylene and benzoylecgonine, was assessed using differential scanning fluorimetry to measure ligand affinities via ligand-induced thermal stabilization of the mAb antigen binding region. Nitrated tyrosine residues were identified by mass spectral analysis of thermolysin peptides. One objective was to understand the binding affinity differences observed for these three ligands, which are not explained by the published crystal structure of the h2E2 mAb Fab fragment co-crystalized with benzoylecgonine, since the carboxylic acid of benzoylecgonine that is esterified to form cocaine and cocaethylene is not in contact with the mAb. Importantly, the binding affinity of the cocaine metabolite benzoylecgonine was not decreased by mild nitration, whereas the binding affinities of cocaine and cocaethylene were decreased about two-fold. These ligands differ only in the substituent attached to the carboxylate moiety of the compound, with benzoylecgonine having an unesterified carboxylate, and cocaine and cocaethylene having methyl and ethyl esters, respectively, at this position. The results are consistent with nitration of light chain tyrosine residue 34, resulting in a less favorable interaction with cocaine and cocaethylene carboxylate esters, while not affecting binding of benzoylecgonine. Thus, light chain Tyr34 residue may have molecular interactions with cocaine and cocaethylene not present for benzoylecgonine, leading to the observed affinity differences for these three ligands.
引用
收藏
页数:6
相关论文
共 43 条
  • [31] A Recombinant Humanized Anti-Cocaine Monoclonal Antibody Inhibits the Distribution of Cocaine to the Brain in Rats (vol 42, pg 1125, 2014)
    Norman, Andrew B.
    Ball, William J.
    DRUG METABOLISM AND DISPOSITION, 2016, 44 (09) : 1460 - 1462
  • [32] Comparison of the pharmacokinetics and time course of effect of the Fab fragment of a humanized anti-cocaine monoclonal antibody in rats
    Marckel, Jordan
    Wetzel, Hanna
    Bell-Howarth, Tiffany
    Turner, Mackenzie
    Webster, Rose
    Norman, Andrew
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (11) : 2583 - 2584
  • [33] Toxicokinetics of a humanized anti-cocaine monoclonal antibody in male and female rats and lack of cross-reactivity
    Webster, Rose P.
    Marckel, Jordan A.
    Norman, Andrew B.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (03)
  • [34] Adenovirus Capsid-Based Anti-Cocaine Vaccine Prevents Cocaine from Binding to the Nonhuman Primate CNS Dopamine Transporter
    Maoz, Anat
    Hicks, Martin J.
    Vallabhjosula, Shankar
    Synan, Michael
    Kothari, Paresh J.
    Dyke, Jonathan P.
    Ballon, Douglas J.
    Kaminsky, Stephen M.
    De, Bishnu P.
    Rosenberg, Jonathan B.
    Martinez, Diana
    Koob, George F.
    Janda, Kim D.
    Crystal, Ronald G.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 (11) : 2170 - 2178
  • [35] Adenovirus Capsid-Based Anti-Cocaine Vaccine Prevents Cocaine from Binding to the Nonhuman Primate CNS Dopamine Transporter
    Anat Maoz
    Martin J Hicks
    Shankar Vallabhjosula
    Michael Synan
    Paresh J Kothari
    Jonathan P Dyke
    Douglas J Ballon
    Stephen M Kaminsky
    Bishnu P De
    Jonathan B Rosenberg
    Diana Martinez
    George F Koob
    Kim D Janda
    Ronald G Crystal
    Neuropsychopharmacology, 2013, 38 : 2170 - 2178
  • [36] The effects of a humanized recombinant anti-cocaine monoclonal antibody on the disposition of cocaethylene in mice (vol 31, pg 387, 2014)
    Wetzel, Hanna N.
    Tabet, Michael R.
    Ball, William J.
    Norman, Andrew B.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 31 : 272 - 273
  • [37] Anti-Cocaine Vaccine dAd5GNE Blocks Cocaine from Binding to the CNS Dopamine Transporter Critical to the Dopamine "Addiction" Pathway
    Hicks, Martin J.
    Vallabhajosula, Shankar
    Maoz, Anat
    Synan, Michael
    Kothari, Paresh J.
    Ballon, Doug
    De, Bishnu P.
    Rosenberg, Jonathan B.
    Koob, George F.
    Janda, Kim D.
    Kaminsky, Stephen M.
    Crystal, Ronald G.
    MOLECULAR THERAPY, 2012, 20 : S32 - S32
  • [38] Characterization of a recombinant humanized anti-cocaine monoclonal antibody produced from multiple clones for the selection of a master cell bank candidate
    Wetzel, Hanna N.
    Webster, Rose P.
    Saeed, Fatima O.
    Kirley, Terence L.
    Ball, William J.
    Norman, Andrew B.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 487 (03) : 690 - 694
  • [39] A Recombinant Humanized Anticocaine Monoclonal Antibody Alters the Urinary Clearance of Cocaine and Its Metabolites in Rats
    Marckel, Jordan A.
    Wetzel, Hanna N.
    Amlal, Sihame
    Amlal, Hassane
    Norman, Andrew B.
    DRUG METABOLISM AND DISPOSITION, 2019, 47 (03) : 184 - 188
  • [40] A novel differential scanning fluorimetry analysis of a humanized anticocaine mAb and its ligand binding characteristics
    Kirley, Terence L.
    Norman, Andrew B.
    Wetzel, Hanna N.
    JOURNAL OF IMMUNOLOGICAL METHODS, 2020, 476